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Abstract
Two community-based cohorts of children with autism spectrum disorder, examined using similar assessment protocols, 
were pooled (n = 301) and subdivided according to history of regression. Those with regression (n = 62), 20.5% of the com-
bined cohort, were contrasted with those without regression (n = 241) at first assessment (age range 19–60 months) and at 
2-year follow-up on a range of measures. The regression group was significantly more functionally impaired, with regard to 
intellectual function (p < .001), language development (p < .001), and to severity of autism (p < .01) at both T1 and T2. Only 
14 (23.3%) had a clearly identified underlying etiology [24 (18.6%) in the non-regressive group]. There were no significant 
differences between those who had regressed ‘from normal’ and those who had regressed ‘from low’ functioning.
Keywords Autism · ASD · Regressive autism · Non-regressive autism · Intellectual developmental disorder · 
Developmental language disorder
Introduction
Many children with autism spectrum disorder (ASD) 
(American Psychiatric Association 2013) have shown mild 
or marked developmental problems from early childhood 
(Coleman and Gillberg 2012). However, regression in a sub-
group of individuals with autism has been recognized for 
decades, indeed for more than a century (Heller 1908), but 
very little population-based research on the phenomenon has 
been published. Where research purports to be population-
based, there are usually still issues with case ascertainment 
as samples do not derive from whole population screening 
(i.e., rely on existing diagnoses within a population (e.g., 
Baird et al. 2008). The few systematic studies that have been 
published seem to indicate that regression in autism is (a) 
not uncommon, but the relative prevalence is not known, and 
(b) associated with high rated of intellectual developmental 
disorder (IDD) in follow-up studies (Bradley et al. 2016; 
Gadow et al. 2017; Shinnar et al. 2001; Stefanatos 2008). 
Some in-depth clinically based studies have suggested a tem-
poral association between regression in autism and epilepsy 
and vice versa (Gadow et al. 2017; Tuchman et al. 2010), 
but this has not been confirmed in population-based surveys 
(Fernell et al. 2010; Kantzer et al. 2013). The role of pos-
sible neuroinflammation in “regressive autism” has been the 
subject of speculation (Pardo et al. 2013) and evidence of 
underlying autoimmune processes and neuroinflammation 
(Scott et al. 2014, 2017) has been suggested. However, very 
little, if any, systematic evidence is available (Kern et al. 
2016).
It is not clear if regressive autism/autism with regres-
sion is the same or different than Heller’s disease or child-
hood disintegrative psychosis/disorder (Coleman and 
Gillberg 2012). The “typical” reported age of regression 
in cases described as regressive autism seems to be about 
18–24(30) months of age (Tuchman 2003; Baird et al. 2008; 
Stefanatos 2008; Hoshino et al. 1987) whereas most cases 
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(albeit certainly not all) of disintegrative disorder (which 
no longer appears in the diagnostic manuals) have been 
reported to show regression after age 30 months (e.g. (Russo 
et al. 1996; Charan 2012)). It is also not known to what 
extent relatively more well-defined disorders with regres-
sion—such as Rett syndrome, with a clear genetic cause, 
and Landau-Kleffner-syndrome, likely, in some cases, with 
a genetic cause (syndromes which are often diagnosed 
with autism)—overlap or indeed account for some cases of 
regressive autism.
In the present report we have combined two of the largest 
in-depth assessed community/population-based preschool 
autism cohorts with a view to establishing (a) the relative 
prevalence of regression in autism, (b) typical associated 
preschool age problems in regressive as compared with 
non-regressive autism, including other Early Symptomatic 
Syndromes Eliciting Neurodevelopmental Clinical Exami-
nation (ESSENCE) (Gillberg 2010) characteristics (e.g., 
hyperactivity), (c) possible predictors, mediators and mod-
erators of regression in autism, including pre- and perinatal 
factors, and (d) specific identified underlying etiologies in 
the Stockholm group. Given the lack of previous systematic 
representative studies in the field, our study sets out to be 
descriptive rather than hypothesis-driven.
Methods
Data from two community-based cohorts were used in the 
present study. The cohorts were recruited in Stockholm and 
in Gothenburg, the two biggest cities in Sweden.
Stockholm Cohort
The Stockholm cohort comprised originally 208 children, 
although one parent has since withdrawn consent for their 
data to be used, so the sample reported here is 207 (32 girls, 
175 boys). They were all cases diagnosed with ASD, accord-
ing to the DSM-IV (American Psychiatric Association 
1994), at their local Child and Adolescent Mental Health 
Service (CAMHS) or neuropediatric clinic from 2005 to 
2008. They are considered to be representative of all chil-
dren with ASD in Stockholm at the time of study, except 
those with very severe co-occurring complex neurological 
syndromes and profound intellectual disability (n = 27) and 
of those with parents not able to communicate in Swedish or 
English for the purpose of the study (n = 15). In addition, 37 
families had declined participation in the study since their 
child had recently had a clinical comprehensive assessment 
at their local CAMHS (Fernell et al. 2010). The male to 
female gender ratio was 5.5:1. Age at diagnosis was between 
2 and 4.5 years and they had all been referred to the special-
ized habilitation center in Stockholm, the Autism Center 
for Young Children (ACYC), to receive intervention. All 
children and parents met with a pediatrician/child and ado-
lescent psychiatrist and were assessed in-depth at the ACYC 
at two time points; at Time 1 (T1) shortly after the child 
had received the diagnosis of ASD and at Time 2 (T2) after 
2 years, during which the child had received intervention. 
At follow-up 197 children participated with their parents 
(Fernell et al. 2010, 2011).
Gothenburg Cohort
The Gothenburg cohort comprised originally 129 children. 
Between 2009 and 2011, all 2.5 year-old children in Gothen-
burg, Sweden underwent a new autism-screening program at 
the Child Health Care centers (Nygren et al. 2012). Children 
who were ‘screen positive’ for suspected ASD were referred 
to Child Neuropsychiatry Clinic (CNC) (Nygren et al. 2012; 
Kantzer et al. 2013). The cohort is clearly population-rep-
resentative as it is based on general population screening 
and detailed assessment and follow-up of all screen posi-
tive cases. All children were assessed by an experienced 
multi-disciplinary team consisting of a neuropsychiatrist, 
a neuropsychologist, a speech-language pathologist and a 
preschool educational diagnostician at study intake (T1). 
In all, 129 children were assessed for suspected ASD (at 
a mean age of 2.9 years); the DSM-IV ASD diagnosis was 
confirmed in 100 children and the remaining 29 presented 
with sub-threshold symptoms of autism, ADHD and devel-
opmental language disorder (DLD). At follow-up, 2 years 
later (T2), 96 of the original 129 children participated with 
their parents (Kantzer et al. 2018).
Measures and Assessment Procedures in the Two 
Cohorts
At T1 and T2, a structured parental interview was used, 
including questions about hereditary factors, the child’s 
development; such as age when the child started unsup-
ported walking, whether toe walking had existed, activity 
level, whether there had been feeding problems during the 
child’s first 2 years (gathered from CHC records in Stock-
holm) and if the child had previous or ongoing treatment 
for epilepsy.
There was also an evaluation of the child’s severity of 
ASD at T1 and T2: in Stockholm this was done using the 
Autistic Behavior Checklist (ABC) score (Krug et al. 1980); 
in Gothenburg the Autism Diagnostic Observation Sched-
ule - Generic (ADOS-G) (Lord et al. 2000) was applied. 
Specific questions were asked regarding whether the child 
had a regressive type of autism, defined as loss of expressive 
language skills (loss of 5 or more words that had been used 
communicatively) in connection with the onset of autism. 
Although the same regression criteria were applied to both 
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cohorts, the classification of cases was slightly different in 
the two cohorts: Gothenburg cases were classified according 
to the timing of regression (i.e., before or after 24 months) 
whereas Stockholm cases were classified according to func-
tional level (i.e., from a “normal” or “low” level, mostly 
close to the same time, around the age of 24 months) (Fer-
nell et al. 2010). In the Stockholm cohort, regression was 
defined as loss of more than five spoken words used com-
municatively in children more than 15 months of age. In 
children younger than 15 months, regression was determined 
when there was a clear indication of loss of social interest 
and contact. Parents were interviewed (in close temporal 
connection to the first diagnostic assessment) regarding a 
history of regression in the child and this information was 
compared to available data in CHC and medical records. 
Consistency was required between parental information and 
the notes in the records from CHC. In one group, parents 
had reported that their child’s general development had been 
“normal” before language regression and in one group par-
ents had had concerns regarding their child’s development 
before regression.
Obstetric records were checked for maternal disorders 
during pregnancy and pregnancy complications and for peri-
natal events. Records from the child’s Health Care Center 
(CHC) were checked with regard to growth charts and devel-
opmental milestones.
A physical examination of the child was performed, 
including an evaluation of muscular tone, physical anoma-
lies, head circumference and skin. Parents were asked about 
etiological diagnoses established and were offered that their 
child could have a genetic test (chromosomal microarray, see 
(Eriksson et al. 2015)) (Gothenburg results still in process, 
so only Stockholm will be reported here).
Children were assessed by a speech and language pathol-
ogist at T1 and T2 and a new cognitive test was performed 
by a psychologist at T2. One of the measures used to assess 
the child’s level of speech and language was the PARIS 
schedule (the Paris Autism Research In Sib-pairs; detailed 
in Fernell et al. 2010) that classified expressive language 
skills into one of five levels: no speech at all, a few single 
words, a few communicative sentences, and phrase speech 
with or without echolalia.
General cognitive/developmental level was assessed 
using either the Griffiths’ test (Alin-Åkerman and Nordberg 
1980), the Wechsler Preschool and Primary Scale of Intel-
ligence (WPPSI-III) (Wechsler 2005), or the Merrill–Palmer 
test (Roid and Sampers 2004). IDD was diagnosed when 
Intellectual Quotient (IQ)/Developmental Quotient (DQ) 
was below 70, combined with a corresponding low general 
adaptive function. borderline intellectual functioning (BIF) 
was diagnosed when the IQ/DQ was between 70 and 84. 
Average intellectual functioning (AIF) was diagnosed when 
IQ/DQ was 85 or above. The child’s adaptive function was 
assessed at T1 and T2 by a parental interview according to 
the Vineland Adaptive Behavior Scales-II (VABS) (Sparrow 
et al. 2005).
Combined Sample
All data were scrutinized, completed (e.g., from medi-
cal records) and compared in 2017 to examine regressive 
cases in both cohorts. The two cohorts were combined for 
some analyses because they were very similar in terms of 
demographics, symptoms and proportion of regressive/non-
regressive cases. The total sample consisted of 303 partici-
pants (49 girls, 254 boys). Tables 1, 2, 6 and 7 indicate the 
variables on which comparisons could validly be made.
Ethics
The Stockholm study was approved by the ethics commit-
tee at Karolinska University Hospital, Stockholm, reference 
number 2006/61–31/2. The Gothenburg study was approved 
by the Regional Ethics Review Board, University of Goth-
enburg, Sweden, registration number 494-08. Informed con-
sent was obtained from at least one of the parents/responsi-
ble carers for each child in both cohorts.
Results
Description of and Comparison Across the Two City 
Cohorts
Although the two cohorts are very similar, there are some 
points on which they differ. With reference to Tables 1 and 
2, children in the Gothenburg cohort were significantly 
younger (T1 3.0 years; T2 5.2 years) on average than those 
in the Stockholm cohort (T1 3.8 years; T2 5.5 years), most 
likely due to the different methods of ascertainment of each 
cohort (i.e., Gothenburg came from a routine whole-popula-
tion screening program, carried out at the age of 2.5 years). 
Around a fifth of each cohort (23.2% and 21.4%, respec-
tively) had parents from different ethnic backgrounds (and 
so likely living in a bilingual household), but Gothenburg 
included a significantly higher proportion of children born 
to non-Swedish parents (see Table 3), most likely due to the 
lack of availability of an interpreter in the Stockholm study. 
Gothenburg children had more siblings and were later in the 
birth order, on average, than Stockholm children. Gothen-
burg children were more likely to be born preterm or beyond 
41 weeks’ gestation than Stockholm children (28% vs 14% 
respectively, see Table 4). Due to the higher degree of ethnic 
diversity in the Gothenburg cohort, we explored whether any 
of these differences were related to parental ethnicity (e.g., 
via cultural preferences regarding family size). Gothenburg 
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families where at least one parent was non-Swedish had sig-
nificantly fewer children (see Table 5). There was no differ-
ence in birth order or gestational age according to parental 
ethnicity.
With reference to Tables  1 and 2, a greater propor-
tion of Gothenburg children had feeding problems in the 
first 2 years, and Stockholm children had poorer language 
development, poorer intellectual ability (VAB scores and 
IQ status), and a higher proportion of children with autism 
(as opposed to autistic-like condition) at T1. The increased 
severity of symptoms in the Stockholm cohort is likely to 
be due to the larger sample size as well as the method of 
ascertainment (i.e., from cases presenting for support, rather 
than from whole-population screening).
Differences Between Those with Regressive (R) 
and non‑regressive (NR) Autism
Just over 20% (62/303) of the combined sample of chil-
dren had regressive autism (see Tables 6, 7). Those with 
regressive autism had a younger age when they first walked 
(R = 13.4; NR = 14.4 months), had a more severe lan-
guage impairment at T1 (R = 71.0%; NR = 41.1%) and T2 
(R = 47.4%; NR = 17.4%) and more often intellectual disabil-
ity (e.g., R = 66.1%; NR = 34.5% at T2), lower mean VAB 
scores at T1 (R = 66.81; NR = 72.24) and T2 (R = 65.07; 
NR = 73.35). Despite the significantly poorer intellectual 
functioning overall, 28 (45.9%) of those with regressive 
autism had an IQ of 70 or greater at T1, 5 of whom were 
regarded as having average intellectual functioning (IQ ≥ 85) 
(see Table 8). Severity of autism was higher in the regres-
sive group, with a higher proportion of children with autism 
(e.g., T1 R = 79.7%, NR = 59.6%) (as opposed to autistic-
like condition (T1 R = 18.6%, NR = 24.6%)). There was no 
difference in levels of hyperactivity between the regressive 
and non-regressive cases, either at T1 or T2. The R and NR 
groups did not differ with regard to the rate of epilepsy; 
at T2, 4 (7.0%) and 18 (7.6%), respectively, had developed 
epilepsy (Table 7). There were also no differences in the rate 
of maternal disease in pregnancy (R = 48.2%, NR = 41.1%). 
The average age at regression was 20.13 months (SD = 9.26) 
with 54 children (88.5%) showing regression by the age of 
24 months (see Table 9).
Regression ‘From Normal’ Versus ‘From Low’
Within the Stockholm sample, where more detailed cod-
ing was applied, 20/46 children classified as regressive had 
followed an apparently normal developmental progression 
prior to regression (whereas the other 26 had regressed 
from an initial low level of functioning). This is partially 
reflected in the language production data, where significantly 
Table 1  Gothenburg and 
Stockholm samples: background 
factors
Significant p values (p < .01) are highlighted in bold
NDD: Neurodevelopmental Disorder
a Specific N for each variable ranged from 88 to 96
b Specific N for each variable ranged from 179 to 207
c chi-squared test
d t-test
e Gbg data from single variable; Stk data compiled from more detailed data: chronic condition, acute condi-
tion, and/or pharmacological intervention in pregnancy
Variables Gbg (n = 96)a Stk (n = 207)b Statistic p
Male (F (%)) 79 (82.3) 175 (84.5) 0.245c 0.621
Age at T1-years (M (SD)) 3.0 (0.53) 3.8 (0.68) -11.165d < 0.001
Age at T2-years (M (SD)) 5.2 (0.53) 5.5 (0.73) -3.364d 0.001
Parents have different ethnicity (F (%)) 22 (23.2) 44 (21.4) 0.123c 0.726
Any NDD in first degree relative? (F (%)) 48 (50.0) 71 (34.29) 6.779c 0.009
Number siblings (M (SD)) 1.62 (0.96) 1.14 (0.81) 4.40d < 0.001
Birth order (M (SD)) 2.09 (0.96) 1.63 (0.77) 1.399d < 0.001
Any maternal disease in pregnancy? (F (%))e 30 (31.3) 87 (48.6) 7.698c 0.006
Gestational age (M (SD)) 39.2 (2.50) 39.1 (2.16) 0.367d 0.714
Born at term (37–41 weeks)? (F (%)) 69 (71.9) 178 (86.0) 8.735c 0.013
Caesarean section? (F (%)) 17 (17.7) 59 (29.2) 4.529c 0.033
Neonatal care? (F (%)) 20 (20.8) 39 (20.0) 0.028c 0.868
Age walking (M (SD)) 13.8 (2.92) 14.5 (4.69) − 1.575d 0.116
Toe walking? (F (%)) 28 (29.2) 70 (33.7) 0.648c 0.421
Feeding problems first 2 years? (F (%)) 46 (47.9) 38 (18.4) 28.599c < 0.001
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fewer of the ‘from normal’ group had no or minimal spoken 
words at T1 compared to the ‘from low’ group (50.0% vs 
84.6%; χ2(1) = 6.398; p = .011), whereas this difference was 
non-significant by T2. There was no significant difference 
in age at first walking, level of intellectual functioning, or 
severity of autism between these subgroups.
Table 2  Gothenburg 
and Stockholm samples: 
measurements and outcomes
Significant p values (p < .01) are highlighted in bold
BIF borderline intellectual functioning, IDD intellectual development disorder, ASD autism spectrum dis-
order
a Specific N for each variable ranged from 79 to 96
b Specific N for each variable ranged from 194 to 207
c chi-squared test
d t-test
Variables Gbg (n = 96)a Stk (n = 207)b Statistic p
Measurements
 Birthweight (M (SD)) 3395.96 (675.78) 3518.24 (623.43) − 1.520d 0.130
 Birthweight SD for gestational age (F (%)) 0.034c 0.983
  ≤ 2SDs 2 (2.2) 4 (2.0)
  Within ± 2SDs 87 (95.6) 194 (95.6)
  ≥ 2SDs 2 (2.2) 5 (2.5)
 Head Circumference (HC) Birth (M (SD)) 34.69 (2.59) 35.08 (1.87) − 1.438d 0.152
 HC Birth SD for gestational age (F (%)) 2.016 c 0.365
  ≤ 2SDs 0 (0) 3 (1.5)
  within ± 2SDs 87 (97.8) 189 (97.4)
  >+ 2SDs 2 (2.2) 2 (1.0)
 HC T1 SD (F (%)) 4.620c 0.099
  ≤ 2SDs 1 (1.3) 2 (1.0)
  within ± 2SDs 71 (89.9) 196 (96.1)
  >+ 2SDs 7 (8.9) 6 (2.9)
Assessment outcomes
 Language T1 − minimal or none (F (%)) 49 (51) 94 (45.4) 0.834c 0.361
 Language T2 − minimal or none (F (%)) 12 (12.5) 56(28.4) 9.186c 0.002
 Activity level T1 − hyper/hypo (F (%)) 36/3 (37.5/3.1) 87/7 (42.0/3.4) 0.612 c 0.736
 Activity level T2 − hyper/hypo (F (%)) 36/3 (37.5/3.1) 103/8 (52.3/4.1) 6.393 c 0.041
 Epilepsy T1 (F (%)) 7 (7.3) 13 (6.3) 0.109c 0.741
 Epilepsy T2 (F (%)) 5 (5.2) 17 (8.5) 1.043c 0.307
 Intellectual level T1 − BIF/IDD (F (%)) 24/30 (25/31.3) 81/78 (39.3/37.9) 14.402c 0.001
 Intellectual level T2 − BIF/IDD (F (%)) 25/25 (26/26) 29/93 (14.9/47.7) 13.490c 0.001
 Vineland total T1 (M (SD)) 76.48 (9.61) 68.81 (10.72) 5.852d < 0.001
 Vineland total T2 (M (SD)) 75.27 (13.36) 69.99 (14.80) 2.891d 0.004
 ASD dx T1-autism/autistic-like (F (%)) 53/23 (55.2/24.0) 137/47 (67.5/23.2) 8.143c 0.017
 ASD dx T2-autism/autistic-like (F (%)) 49/30 (51.0/31.3) 104/72 (52.8/36.5) 3.031c 0.220
Table 3  Ethnic background of children in Gothenburg and Stockholm 
cohorts
Significant p value (p < .05) is highlighted in bold
Parents’ ethnicity Gbg (F (%)) Stk (F (%)) χ2 df p
Both Swedish 42 (44.2) 123 (59.4)
All other ethnicities 53 (55.8) 84 (40.6) 6.078 1 0.014
Table 4  Gestational period of children in Gothenburg and Stockholm 
cohorts
Significant p value (p < .05) is highlighted in bold
Gestational period Gbg (F (%)) Stk (F (%)) χ2 df p
Pre term < 37 weeks 12 (12.5) 12 (5.8)
Term 37–41 weeks 69 (71.9) 178 (86.0)
Post term > 41 weeks 15 (15.6) 17 (8.2) 8.735 0.013
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Genetic Etiology (Stockholm Only)
As Gothenburg genetic analysis is ongoing for the total 
sample, we will report only the Stockholm figures here. 
In Stockholm, 169 participants provided genetic sam-
ples and 33 (20.0%) showed clear genetic abnormalities. 
A further 3 were assessed clinically as having tuberous 
sclerosis (bringing the proportion of known genetic etiol-
ogy to 20.9%). Of those with regressive autism, 40 (87%) 
of the 46 cases in the sample underwent genetic testing. 
Ten (25%) of these showed a clear genetic abnormal-
ity, including 3 with a CNV and 1 with Rett syndrome. 
A further 3 individuals had identified underlying etiol-
ogy with a normal genetic outcome: 1 had been born 
extremely preterm (24 weeks), 1 had encephalitis, and 1 
had neuroblastoma. Therefore, of the 46 cases of regres-
sive autism in the Stockholm group, 13 (28.3%) had a 
clearly identified underlying etiology. As Table 10 shows, 
there was no significant difference in the proportion with 
a genetic abnormality in the R and NR groups within the 
Stockholm sample.
There were two cases of Rett syndrome within the 
Stockholm sample. One had regressive autism (from 
normal) and the other did not. There was little difference 
between the two cases apart from the girl with regressive 
autism apparently showing greater regression within the 
time of measurement (i.e., from T1 to T2 her intellectual 
functioning moved from BIF to IDD).
Table 5  Number of siblings and 
birth order in Gothenburg by 
parental ethnicity
Significant p value (p < .05) is highlighted in bold
Both parents Swedish
Mean (SD)
All other ethnicities
Mean (SD)
t p
Number of siblings 1.85 (1.189) 1.42 (0.702) − 2.136 0.035
Birth order 2.23 (1.143) 1.98 (0.795) −  1.197 0.235
Table 6  Regression and Non-
regression cases: background 
factors
Significant p value (p < .01) is highlighted in bold
NDD Neurodevelopmental Disorder
a Specific N for each variable ranged from 56 to 62
b Specific N for each variable ranged from 219 to 241
c chi-squared test
d t-test
e Gbg data from single variable; Stk data compiled from more detailed data: chronic condition, acute condi-
tion, and/or pharmacological intervention in pregnancy
Variables R (n = 62)a NR (n = 241)b Statistic p
Background
 Male (F (%)) 54 (87.1) 200 (83.0) 0.614c 0.433
 Age at T1-years (M (SD)) 3.5 (0.68) 3.5 (0.76) 0.216d 0.829
 Age at T2-years (M (SD)) 5.4 (0.65) 5.4 (0.69) 0.316d 0.752
 Parents have different ethnicity (F (%)) 17 (27.4) 49 (20.5) 1.376c 0.241
 Any NDD in first degree relative? (F (%)) 24 (38.7) 95 (39.4) 0.010c 0.919
 Number siblings (M (SD)) 1.30 (0.80) 1.28 (0.90) − 0.088d 0.930
 Birth order (M (SD)) 1.77 (0.89) 1.77 (0.85) 0.031d 0.975
 Any maternal disease in pregnancy? (F (%))e 27 (48.2) 90 (41.1) 0.924c 0.336
 Gestational age (M (SD)) 39.22 (2.81) 39.11 (2.10) − 0.317d 0.751
 Born at term (37–41 weeks)? (F (%)) 46 (74.2) 201 (83.4) 2.785c 0.248
 Caesarean section? (F (%)) 16 (25.8) 60 (25.4) 0.004c 0.951
 Neonatal care? (F (%)) 9 (14.8) 50 (21.7) 1.455c 0.228
 Age walking − months (M (SD)) 13.4 (2.72) 14.4 (4.51) 2.188d 0.030
 Toe walking? (F (%)) 24 (38.7) 74 (30.7) 1.444c 0.230
 Feeding problems first 2 years? (F (%)) 18 (29.0) 66 (27.4) 0.067c 0.796
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Discussion
This study aimed to describe systematically a sub-population 
of children with ASD and early developmental regression 
derived from a whole population base in Sweden’s two larg-
est cities, and to examine how those with early regression 
compare to those without. We have chosen to focus on lan-
guage regression specifically (rather than social, play or motor 
regression) as communication is by far the most common skill 
to be lost or diminished in regressive autism (Gadow et al. 
2017). However, in children younger than 15 months, regres-
sion was determined when there was a clear indication of loss 
of social interest and contact. We believe that this is one of the 
very few relatively large-scale in-depth population studies of 
‘regressive autism’. In a recent review, for example, 12 of the 
85 articles meeting inclusion criteria were described as ‘popu-
lation’ based (although it is impossible to tell from the review 
article how many of these involved whole population screen-
ing) (Barger et al. 2013). In our rare example of a large-scale 
population-based study of children with regressive autism, we 
Table 7  Regression and Non-
regression cases: measurement 
and assessment outcomes
Significant p values (p < .01) are highlighted in bold
BIF borderline intellectual functioning, IDD intellectual development disorder,, ASD autism spectrum dis-
order
a Specific N for each variable ranged from 55 to 62
b Specific N for each variable ranged from 224 to 241
c chi-squared test
d t-test
e Gbg data from single variable; Stk data compiled from more detailed data: chronic condition, acute condi-
tion, and/or pharmacological intervention in pregnancy
Variables R (n = 62)a NR (n = 241)b Statistic p
Measurements
 Birthweight (M (SD)) 3431.60 (662.46) 3493.85 (636.31) 0.680d 0.797
 Birthweight SD for gestational age (F (%)) 0.277c 0.871
  ≤ 2SDs 1 (1.6) 5 (2.2)
  within ± 2SDs 60 (96.8) 221 (95.3)
  >+ 2SDs 1 (1.6) 6 (2.6)
 Head Circumference (HC) Birth (M (SD)) 34.88 (3.15) 34.97 (1.76) 0.235d 0.815
 HC Birth SD for gestational age (F (%)) 1.342c 0.511
  < 2SDs 1 (1.7) 2 (0.9)
  within ± 2SDs 58 (98.3) 218 (97.3)
  ≥ 2SDs 0 (0) 4 (1.8)
 HC T1 (M (SD)) 51.33 (1.94) 51.19 (1.83) − 0.498d 0.619
 HC T1 SD (F (%)) 3.613c 0.164
  < 2SDs 1 (1.8) 2 (0.9)
  within ± 2SDs 54 (98.2) 212 (93.4)
  ≥ 2SDs 0 (0) 13 (5.7)
Assessment outcomes
 Language T1 − minimal or none (F (%)) 44 (71) 99 (41.1) 17.667c < 0.001
 Language T2 − minimal or none (F (%)) 27 (47.4) 41 (17.4) 23.178c < 0.001
 Activity level T1 − hyper/hypo (F (%)) 25/3 (40.3/4.8) 98/7 (40.7/2.9) 0.583c 0.747
 Activity level T2 − hyper/hypo (F (%)) 22/3 (38.6/5.3) 117/8 (49.6/3.4) 2.736c 0.305
 Epilepsy T1 (F (%)) 4 (4.1) 16 (6.6) 0.003c 0.958
 Epilepsy T2 (F (%)) 4 (7.0) 18 (7.6) 0.020c 0.888
 Intellectual level T1 − BIF/IDD (F (%)) 23/33 (37.7/54.1) 82/75 (34.0/31.1) 19.115c < 0.001
 Intellectual level T2 − BIF/IDD (F (%)) 12/37 (21.4/66.1) 42/81 (17.9/34.5) 25.118c < 0.001
 Vineland total T1 (M (SD)) 66.81 (10.76) 72.24 (10.77) 3.420d 0.001
 Vineland total T2 (M (SD)) 65.07 (14.49) 73.35 (14.12) 3.939d < 0.001
 ASD dx T1 − autism/autistic-like (F (%)) 47/11 (79.7/18.6) 143/59 (59.6/24.6) 10.976c 0.004
 ASD dx T2 autism/autistic-like (F (%)) 43/12 (75.4/21.1) 110/90 (46.6/38.1) 16.039c < 0.001
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found that regression occurs in about one in five of all chil-
dren with ASD and that about half this proportion constitutes 
“regression from normal”. The regressive and non-regressive 
groups differ in expected ways—in general, poorer language 
development, poorer intellectual function, and greater severity 
of autism in those with regression. We also found that children 
with regressive autism began walking at an earlier age than 
children with non-regressive autism supporting the notion 
that many of them had indeed had ‘normal’ early develop-
ment before the regression occurred. There were no differences 
between those who regressed from a relatively normal level 
of functioning and those who were already experiencing some 
impairment, with the exception of language production which 
was less impaired in the ‘from normal’ subgroup.
The rate of epilepsy among children in the regressive 
compared to the non-regressive group was similar, around 
7%, a finding supported by the study from Baird et  al. 
(2006), reporting no significant difference in epileptiform 
activities between children with regression and no regres-
sion. There was also a similar level of maternal disease in 
pregnancy in the regressive and non-regressive groups, sug-
gesting that prenatal exposure via maternal disease does not 
seem to be a key feature in the development of regressive 
autism. Only 13 of the 46 Stockholm regressive autism cases 
(28%) had a clearly identified underlying etiology, a similar 
proportion to those without regression, with similar propor-
tions (80/87%) undergoing genetic testing (chromosomal 
microarray) in either group.
The prevalence rate of around 20% in this population is 
in keeping with that found in previous research, e.g., Barger 
and colleagues (2013) found an average prevalence rate of 
21.8% among population samples (as opposed to 33.6% 
from clinical samples). The poorer functioning, especially in 
relation to language skills, is also in keeping with previous 
literature. We have also confirmed the finding that children 
with regressive autism walk at an earlier age, previously 
shown in a smaller, clinically-derived sample (Jones and 
Campbell 2010).
It is important to consider issues of case ascertainment, 
screening and assessment approaches, and definition of 
regression in placing this study within the extant literature. It 
is a limitation of the present study that the Stockholm group 
was recruited on the basis of the diagnosis of ASD and the 
Gothenburg group after screening and diagnosis render con-
clusions about the representativity of the samples a bit dif-
ficult. Nevertheless, both groups were originally community 
(rather than clinic) based and relatively large, and the results 
are likely to be more representative of ASD than those of 
previously published studies that have almost always been 
clinic based with no clue as to the basis of recruitment in 
the general population. We used language regression specifi-
cally for defining regression (as opposed to language / social 
regression or ‘mixed’ regression—see Barger et al. 2013) 
but this has not been applied in exactly the same manner 
in the two sub-cohorts. Gothenburg cases were classified 
according to the timing of regression (i.e., before or after 
24 months) whereas Stockholm cases were classified accord-
ing to functional level (i.e., from a “normal” or “low” level, 
mostly close to the same time, around the age of 24 months). 
Application of a generally agreed definition of regression, as 
well as a standardised assessment protocol, would enhance 
our ability to generate large datasets for robust analyses.
Ozonoff et al. (2018) studied aspects concerning the defi-
nition of regression in autism. A finding was that regres-
sive forms of onset in autism might be under-reported using 
certain methods. Four measures were studied; informant 
(examiner vs. parent), the decision type (categorical [regres-
sion absent or present] vs. dimensional [frequency of social 
behaviors]), and the timing of the assessment (retrospec-
tive vs. prospective). A finding in their study was that the 
accuracy of widely used methods of measuring onset is 
Table 8  Intellectual function in regression and non-regression cases
Note: Significant p values (p < .01) are highlighted in bold
Intellectual level R
F (%)
NR
F (%)
χ2 p
T1
 AIF 5 (8.2) 84 (34.9)
 BIF 23 (37.7) 82 (34.0)
 IDD 33 (54.1) 75 (31.1) 19.115 < 0.001
T2
 AIF 7 (12.5) 112 (47.7)
 BIF 12 (21.4) 42 (17.9)
 IDD 37 (66.1) 81 (34.5) 25.118 < 0.001
Table 9  Age at regression Min Max Median IQR Mean SD
Age of regression (months) n = 61 11 63 18 15–21.5 20.13 9.262
Table 10  Genetic etiology in regression and non-regression cases 
(Stockholm sample)
Genetic abnor-
mality identified
R
F (%)
NR
F (%)
χ2 df p
Yes 10 (25.0) 28 (21.2)
No 30 (75.0) 104 (78.8) 0.613 1 0.613
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questionable and that the present findings argue against their 
widespread use.
This study nevertheless presents a rare examination of 
two community-based samples using similar assessment 
protocols both at original assessment and at follow-up, and 
with in-depth examinations of all cases. Future research 
should address the limitations around case ascertainment, 
method of screening / diagnosis and definition of regression, 
as well as expand to even larger population-based cohorts 
and include long term follow-up. With regard to the under-
lying cause/s of early regressive autism, we are in need of 
large collaborative studies to further explore immunological, 
metabolic and genetic mechanisms, synaptic and neurotrans-
mitter signaling abnormalities, and other possible etiopatho-
logical mechanisms.
In a recent paper, Thurm et al. (2018) reported from a 
meeting convened by the National Institutes of Health (NIH) 
in 2016 on: “Loss of Skills and Onset Patterns in Neurode-
velopmental Disorders: Understanding the Neurobiological 
Mechanisms”. With regard to recommendations and next 
steps, the authors discussed that regression is not a discrete 
event but a process, and it is dimensional rather than cat-
egorical. The need to understand the various neurobiologi-
cal processes of synaptogenesis and pruning in ASD, and 
other neurodevelopmental disorders, using different models, 
including novel non-invasive methods was highlighted.
Clinical Implications
Regression is not uncommon in ASD (occurring in about 
one in five of all cases of which half represent “regression 
from normal”), but sufficiently frequent to warrant careful 
consideration in all new cases with autism. Further, there is 
a need to make holistic and follow-up examinations of all 
children with ASD and perhaps particularly detailed assess-
ments of all those in whom there is suspicion or proof of 
regression/loss of skills. Children with a regressive devel-
opmental trajectory, with or without autism, always need a 
careful neuropediatric work-up to investigate possible neuro-
logical disorders that may lead to developmental regression, 
taking into account possible treatable conditions.
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